nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.148	0.151	CbGbCtD
Rilpivirine—ABCG2—Sulfasalazine—ankylosing spondylitis	0.118	0.12	CbGbCtD
Rilpivirine—SLCO1B3—Methotrexate—ankylosing spondylitis	0.102	0.104	CbGbCtD
Rilpivirine—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0594	0.0607	CbGbCtD
Rilpivirine—ABCG2—Dexamethasone—ankylosing spondylitis	0.0587	0.06	CbGbCtD
Rilpivirine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0559	0.0572	CbGbCtD
Rilpivirine—ABCG2—Methotrexate—ankylosing spondylitis	0.0472	0.0482	CbGbCtD
Rilpivirine—CYP2C19—Prednisone—ankylosing spondylitis	0.042	0.043	CbGbCtD
Rilpivirine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0413	0.0422	CbGbCtD
Rilpivirine—ABCB1—Betamethasone—ankylosing spondylitis	0.0364	0.0372	CbGbCtD
Rilpivirine—ABCB1—Prednisolone—ankylosing spondylitis	0.0359	0.0367	CbGbCtD
Rilpivirine—ABCB1—Prednisone—ankylosing spondylitis	0.0339	0.0347	CbGbCtD
Rilpivirine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0335	0.0343	CbGbCtD
Rilpivirine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0262	0.0268	CbGbCtD
Rilpivirine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0254	0.026	CbGbCtD
Rilpivirine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0218	0.0223	CbGbCtD
Rilpivirine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0215	0.022	CbGbCtD
Rilpivirine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0212	0.0216	CbGbCtD
Rilpivirine—CYP3A4—Prednisone—ankylosing spondylitis	0.0203	0.0208	CbGbCtD
Rilpivirine—ABCB1—Methotrexate—ankylosing spondylitis	0.017	0.0174	CbGbCtD
Rilpivirine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0127	0.013	CbGbCtD
Rilpivirine—Buffalo hump—Prednisone—ankylosing spondylitis	0.00149	0.0664	CcSEcCtD
Rilpivirine—Adrenal insufficiency—Prednisone—ankylosing spondylitis	0.00143	0.0636	CcSEcCtD
Rilpivirine—Lipohypertrophy—Prednisone—ankylosing spondylitis	0.00137	0.061	CcSEcCtD
Rilpivirine—Opportunistic infection—Methylprednisolone—ankylosing spondylitis	0.00094	0.0418	CcSEcCtD
Rilpivirine—Opportunistic infection—Betamethasone—ankylosing spondylitis	0.000855	0.038	CcSEcCtD
Rilpivirine—Opportunistic infection—Dexamethasone—ankylosing spondylitis	0.000855	0.038	CcSEcCtD
Rilpivirine—Depressed mood—Methylprednisolone—ankylosing spondylitis	0.000847	0.0376	CcSEcCtD
Rilpivirine—Opportunistic infection—Prednisone—ankylosing spondylitis	0.000744	0.0331	CcSEcCtD
Rilpivirine—Opportunistic infection—Methotrexate—ankylosing spondylitis	0.000622	0.0277	CcSEcCtD
Rilpivirine—Inflammation—Methylprednisolone—ankylosing spondylitis	0.00039	0.0174	CcSEcCtD
Rilpivirine—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.000324	0.0144	CcSEcCtD
Rilpivirine—Inflammation—Methotrexate—ankylosing spondylitis	0.000258	0.0115	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000242	0.0108	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000192	0.00853	CcSEcCtD
Rilpivirine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000172	0.00763	CcSEcCtD
Rilpivirine—Depression—Prednisone—ankylosing spondylitis	0.000167	0.00743	CcSEcCtD
Rilpivirine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000167	0.0074	CcSEcCtD
Rilpivirine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000165	0.00736	CcSEcCtD
Rilpivirine—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000151	0.0067	CcSEcCtD
Rilpivirine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00014	0.00624	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00014	0.00622	CcSEcCtD
Rilpivirine—Depression—Methotrexate—ankylosing spondylitis	0.00014	0.00621	CcSEcCtD
Rilpivirine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000138	0.00614	CcSEcCtD
Rilpivirine—Renal failure—Methotrexate—ankylosing spondylitis	0.000138	0.00613	CcSEcCtD
Rilpivirine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000136	0.00605	CcSEcCtD
Rilpivirine—Infection—Triamcinolone—ankylosing spondylitis	0.000134	0.00598	CcSEcCtD
Rilpivirine—Infection—Methylprednisolone—ankylosing spondylitis	0.000134	0.00597	CcSEcCtD
Rilpivirine—Insomnia—Prednisolone—ankylosing spondylitis	0.000133	0.00592	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000133	0.00589	CcSEcCtD
Rilpivirine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000132	0.00589	CcSEcCtD
Rilpivirine—Mental disorder—Prednisone—ankylosing spondylitis	0.000132	0.00586	CcSEcCtD
Rilpivirine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000131	0.00583	CcSEcCtD
Rilpivirine—Malnutrition—Prednisone—ankylosing spondylitis	0.000131	0.00583	CcSEcCtD
Rilpivirine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000128	0.00568	CcSEcCtD
Rilpivirine—Anxiety—Betamethasone—ankylosing spondylitis	0.000128	0.00568	CcSEcCtD
Rilpivirine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000124	0.00552	CcSEcCtD
Rilpivirine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000123	0.00548	CcSEcCtD
Rilpivirine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000122	0.00544	CcSEcCtD
Rilpivirine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000122	0.00543	CcSEcCtD
Rilpivirine—Infection—Betamethasone—ankylosing spondylitis	0.000122	0.00542	CcSEcCtD
Rilpivirine—Infection—Dexamethasone—ankylosing spondylitis	0.000122	0.00542	CcSEcCtD
Rilpivirine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00012	0.00535	CcSEcCtD
Rilpivirine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00012	0.00535	CcSEcCtD
Rilpivirine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000117	0.00519	CcSEcCtD
Rilpivirine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000116	0.00518	CcSEcCtD
Rilpivirine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000114	0.00505	CcSEcCtD
Rilpivirine—Anxiety—Prednisone—ankylosing spondylitis	0.000111	0.00494	CcSEcCtD
Rilpivirine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000111	0.00494	CcSEcCtD
Rilpivirine—Insomnia—Betamethasone—ankylosing spondylitis	0.000111	0.00494	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000111	0.00493	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00011	0.00491	CcSEcCtD
Rilpivirine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00011	0.0049	CcSEcCtD
Rilpivirine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00011	0.00487	CcSEcCtD
Rilpivirine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000107	0.00475	CcSEcCtD
Rilpivirine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000107	0.00475	CcSEcCtD
Rilpivirine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000107	0.00475	CcSEcCtD
Rilpivirine—Infection—Prednisone—ankylosing spondylitis	0.000106	0.00472	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000106	0.00471	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000106	0.00471	CcSEcCtD
Rilpivirine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000106	0.00471	CcSEcCtD
Rilpivirine—Fatigue—Betamethasone—ankylosing spondylitis	0.000106	0.00471	CcSEcCtD
Rilpivirine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000105	0.00466	CcSEcCtD
Rilpivirine—Skin disorder—Prednisone—ankylosing spondylitis	0.000104	0.00462	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0001	0.00446	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0001	0.00446	CcSEcCtD
Rilpivirine—Dizziness—Prednisolone—ankylosing spondylitis	9.73e-05	0.00433	CcSEcCtD
Rilpivirine—Asthenia—Triamcinolone—ankylosing spondylitis	9.71e-05	0.00432	CcSEcCtD
Rilpivirine—Abdominal pain—Betamethasone—ankylosing spondylitis	9.71e-05	0.00432	CcSEcCtD
Rilpivirine—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.71e-05	0.00432	CcSEcCtD
Rilpivirine—Asthenia—Methylprednisolone—ankylosing spondylitis	9.69e-05	0.00431	CcSEcCtD
Rilpivirine—Insomnia—Prednisone—ankylosing spondylitis	9.67e-05	0.0043	CcSEcCtD
Rilpivirine—Decreased appetite—Prednisone—ankylosing spondylitis	9.3e-05	0.00413	CcSEcCtD
Rilpivirine—Rash—Prednisolone—ankylosing spondylitis	9.28e-05	0.00413	CcSEcCtD
Rilpivirine—Dermatitis—Prednisolone—ankylosing spondylitis	9.27e-05	0.00412	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	9.26e-05	0.00412	CcSEcCtD
Rilpivirine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	9.24e-05	0.00411	CcSEcCtD
Rilpivirine—Fatigue—Prednisone—ankylosing spondylitis	9.22e-05	0.0041	CcSEcCtD
Rilpivirine—Headache—Prednisolone—ankylosing spondylitis	9.22e-05	0.0041	CcSEcCtD
Rilpivirine—Dizziness—Triamcinolone—ankylosing spondylitis	8.95e-05	0.00398	CcSEcCtD
Rilpivirine—Dizziness—Methylprednisolone—ankylosing spondylitis	8.93e-05	0.00397	CcSEcCtD
Rilpivirine—Infection—Methotrexate—ankylosing spondylitis	8.88e-05	0.00395	CcSEcCtD
Rilpivirine—Asthenia—Dexamethasone—ankylosing spondylitis	8.81e-05	0.00392	CcSEcCtD
Rilpivirine—Asthenia—Betamethasone—ankylosing spondylitis	8.81e-05	0.00392	CcSEcCtD
Rilpivirine—Nervous system disorder—Methotrexate—ankylosing spondylitis	8.77e-05	0.0039	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.75e-05	0.00389	CcSEcCtD
Rilpivirine—Nausea—Prednisolone—ankylosing spondylitis	8.74e-05	0.00389	CcSEcCtD
Rilpivirine—Skin disorder—Methotrexate—ankylosing spondylitis	8.68e-05	0.00386	CcSEcCtD
Rilpivirine—Vomiting—Triamcinolone—ankylosing spondylitis	8.61e-05	0.00383	CcSEcCtD
Rilpivirine—Vomiting—Methylprednisolone—ankylosing spondylitis	8.59e-05	0.00382	CcSEcCtD
Rilpivirine—Rash—Triamcinolone—ankylosing spondylitis	8.54e-05	0.00379	CcSEcCtD
Rilpivirine—Dermatitis—Triamcinolone—ankylosing spondylitis	8.53e-05	0.00379	CcSEcCtD
Rilpivirine—Rash—Methylprednisolone—ankylosing spondylitis	8.52e-05	0.00379	CcSEcCtD
Rilpivirine—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.51e-05	0.00378	CcSEcCtD
Rilpivirine—Headache—Triamcinolone—ankylosing spondylitis	8.48e-05	0.00377	CcSEcCtD
Rilpivirine—Headache—Methylprednisolone—ankylosing spondylitis	8.46e-05	0.00376	CcSEcCtD
Rilpivirine—Abdominal pain—Prednisone—ankylosing spondylitis	8.46e-05	0.00376	CcSEcCtD
Rilpivirine—Diarrhoea—Dexamethasone—ankylosing spondylitis	8.4e-05	0.00374	CcSEcCtD
Rilpivirine—Diarrhoea—Betamethasone—ankylosing spondylitis	8.4e-05	0.00374	CcSEcCtD
Rilpivirine—Dizziness—Dexamethasone—ankylosing spondylitis	8.12e-05	0.00361	CcSEcCtD
Rilpivirine—Dizziness—Betamethasone—ankylosing spondylitis	8.12e-05	0.00361	CcSEcCtD
Rilpivirine—Insomnia—Methotrexate—ankylosing spondylitis	8.09e-05	0.00359	CcSEcCtD
Rilpivirine—Nausea—Triamcinolone—ankylosing spondylitis	8.04e-05	0.00357	CcSEcCtD
Rilpivirine—Nausea—Methylprednisolone—ankylosing spondylitis	8.02e-05	0.00357	CcSEcCtD
Rilpivirine—Somnolence—Methotrexate—ankylosing spondylitis	7.95e-05	0.00353	CcSEcCtD
Rilpivirine—Vomiting—Betamethasone—ankylosing spondylitis	7.81e-05	0.00347	CcSEcCtD
Rilpivirine—Vomiting—Dexamethasone—ankylosing spondylitis	7.81e-05	0.00347	CcSEcCtD
Rilpivirine—Decreased appetite—Methotrexate—ankylosing spondylitis	7.77e-05	0.00345	CcSEcCtD
Rilpivirine—Rash—Betamethasone—ankylosing spondylitis	7.74e-05	0.00344	CcSEcCtD
Rilpivirine—Rash—Dexamethasone—ankylosing spondylitis	7.74e-05	0.00344	CcSEcCtD
Rilpivirine—Dermatitis—Dexamethasone—ankylosing spondylitis	7.74e-05	0.00344	CcSEcCtD
Rilpivirine—Dermatitis—Betamethasone—ankylosing spondylitis	7.74e-05	0.00344	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	7.72e-05	0.00343	CcSEcCtD
Rilpivirine—Fatigue—Methotrexate—ankylosing spondylitis	7.71e-05	0.00343	CcSEcCtD
Rilpivirine—Headache—Betamethasone—ankylosing spondylitis	7.69e-05	0.00342	CcSEcCtD
Rilpivirine—Headache—Dexamethasone—ankylosing spondylitis	7.69e-05	0.00342	CcSEcCtD
Rilpivirine—Asthenia—Prednisone—ankylosing spondylitis	7.67e-05	0.00341	CcSEcCtD
Rilpivirine—Diarrhoea—Prednisone—ankylosing spondylitis	7.32e-05	0.00325	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	7.31e-05	0.00325	CcSEcCtD
Rilpivirine—Nausea—Betamethasone—ankylosing spondylitis	7.3e-05	0.00324	CcSEcCtD
Rilpivirine—Nausea—Dexamethasone—ankylosing spondylitis	7.3e-05	0.00324	CcSEcCtD
Rilpivirine—Dizziness—Prednisone—ankylosing spondylitis	7.07e-05	0.00314	CcSEcCtD
Rilpivirine—Abdominal pain—Methotrexate—ankylosing spondylitis	7.07e-05	0.00314	CcSEcCtD
Rilpivirine—Vomiting—Prednisone—ankylosing spondylitis	6.8e-05	0.00302	CcSEcCtD
Rilpivirine—Rash—Prednisone—ankylosing spondylitis	6.74e-05	0.003	CcSEcCtD
Rilpivirine—Dermatitis—Prednisone—ankylosing spondylitis	6.74e-05	0.003	CcSEcCtD
Rilpivirine—Headache—Prednisone—ankylosing spondylitis	6.7e-05	0.00298	CcSEcCtD
Rilpivirine—Asthenia—Methotrexate—ankylosing spondylitis	6.41e-05	0.00285	CcSEcCtD
Rilpivirine—Nausea—Prednisone—ankylosing spondylitis	6.35e-05	0.00282	CcSEcCtD
Rilpivirine—Diarrhoea—Methotrexate—ankylosing spondylitis	6.12e-05	0.00272	CcSEcCtD
Rilpivirine—Dizziness—Methotrexate—ankylosing spondylitis	5.91e-05	0.00263	CcSEcCtD
Rilpivirine—Vomiting—Methotrexate—ankylosing spondylitis	5.68e-05	0.00253	CcSEcCtD
Rilpivirine—Rash—Methotrexate—ankylosing spondylitis	5.64e-05	0.00251	CcSEcCtD
Rilpivirine—Dermatitis—Methotrexate—ankylosing spondylitis	5.63e-05	0.0025	CcSEcCtD
Rilpivirine—Headache—Methotrexate—ankylosing spondylitis	5.6e-05	0.00249	CcSEcCtD
Rilpivirine—Nausea—Methotrexate—ankylosing spondylitis	5.31e-05	0.00236	CcSEcCtD
